Danielle Brown, oncology account manager, Amgen
Jamal Brown, director of quality, The Medicines Company
Michelle Burris, chief operating officer, Trubion Pharmaceuticals
Jim Caggiano, vice president of sales and marketing, Allergan
Liz Cardwell, quality assurance/regulatory consultant
Feng Chen, senior associate scientist, MDRNA
Nathan Christensen, senior purchasing agent, Trubion Pharmaceuticals
Douglas Clark, technical consultant, Scherer & Associates
Matthew Croughan, George B. and Joy Rathmann professor, director of the Amgen Bioprocessing Center, Keck Graduate Institute [Added: 5:40 pm, 5/10/10]
Rick Dejong, senior systems and reporting analyst, Marchex
Justine Dell’Aringa, senior associate scientist, Amgen
Nancy Deroux, regulatory operations manager, Novartis Vaccines
Michael Diegel, scientist, Revalesio [Added: 3:12 pm, 9/27/10]
Petra Duterrow, senior buyer, F5
Julie Eastland, chief financial officer, VLST
Deborah Elvins, managing member, Adkins, Plant, Elvins & Black
John Emswiler, scientist, Micronics
Ken Farah, managing director, BiologicResponse [Added: 8:50 pm, 4/1/10]
Richard Gaeto, vice President, CMC operations, ZymoGenetics [Added: 3:20 pm, 3/31/10]
Pete Garcia, chief financial officer, MDRNA
Dennis George, arbitrator
Monique Greer, vice president corporate communications/investor relations, Allos Therapeutics
Helen Halloran, IP and contract paralegal, office support
Lori Hansen, director of project management, Seattle Genetics
Wes Hargraves, chief financial officer-Americas, Intec Telecom
Christopher Henney, chairman of the board, Oncothyreon, director, AVI Biopharma
Rob Hershberg, co-founder, executive vice president of R&D, VentiRx Pharmaceuticals
Rob Hill, senior medical writing specialist, Gilead Sciences
Lisa Johnson, graduate research assistant, microbiology, immunology and cancer biology Ph.D. program, University of Minnesota
Lori Jones, biotechnology professional
Jelle Kylstra, independent biotechnology professional
Reiner Laus, CEO, BN ImmunoTherapeutics
